Life Sciences Cases To Watch In 2013

Law360, New York (January 1, 2013, 5:16 PM EST) -- A thick docket of high-stakes life sciences cases will be decided in 2013, dramatically impacting how pharmaceutical companies market their products, what they can patent and when they face competition for their drugs.

Depending on which way things go, the sector could emerge facing an entirely new landscape, or the status quo might be affirmed, said Tripp Haston, co-chairman of the life sciences team at Bradley Arant Boult Cummings. "2013 could prove to be watershed or will-o-wisp in terms of emerging trends for the life sciences...
To view the full article, register now.